US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Invesco S&P 500 Equal Weight Health Care ETF

36.30

-0.1900-0.52%

Post-market: 36.300.00000.00%19:30 EDT

Volume:85.62K

Turnover:3.11M

Market Cap:838.17M

PE:- -

High:36.50

Open:36.41

Low:36.20

Close:36.49

52wk High:38.19

52wk Low:28.26

Shares:23.09M

Float Shares:23.09M

Volume Ratio:0.29

T/O Rate:0.37%

Dividend:0.23

Dividend Rate:0.64%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Tellgen's Subsidiary Device Registration Application Accepted by Regulator

LIFETECH SCI's LantvalTM Aortic Valve Replacement System Clears NMPA Fast-Track Review for Innovative Devices

Bank of America Reveals 5.22% Indirect Stake in Qiagen

Revvity to acquire Human Cell Design

Actinogen Medical Expands ASX-Quoted Share Base

Structure weakness ‘disconnected’ from underlying data, says Jefferies

Structure Therapeutics reports ACCG-2671, aleniglipron trial results

CSL Seeks ASX Quotation for New Shares from Employee Incentive Plan

Ceryvyn Therapeutics Plans Issue of 3 Million Long-Dated Options

China Securities Reports Medical Device Sector Sustains Earnings Improvement While Medical Services Revenue Grows Steadily

Novo Nordisk's GLP-1 Drug Shows Promise in Reducing Childhood Obesity in Younger Kids

Medical Device Inspection Campaign Launched by Ningyang County Market Regulators

MedTech Firm Joins Hong Kong Market: Evaluating MEDCAPTAIN's (02041) True Investment Potential

Qurient Plans Investor Roadshow at 2026 KIS BioTech Day in Singapore and Hong Kong

Brain-Computer Interface Startups Must Walk the Line Between Vast Potential and Near-Term Medical Reality, Says Formatia Founder

Guardant announces FDA approval of Guardant360 CDx as companion diagnostic

AcroMeta Moves Into Cell Therapy Logistics With Southeast Asia ATCLS Deal

SD Biotechnologies Faces KOSDAQ Delisting Decision After Improvement Period

Yinchuan Market Regulators Roll Out Comprehensive Measures to Implement Revised Medical Device Production Quality Standards

Alterity Therapeutics to Spotlight MSA Program at Cantor Global Healthcare Conference

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/stock/RSPH/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RSPH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RSPH\",,,,,undefined,":{"symbol":"RSPH","market":"US","secType":"STK","nameCN":"Invesco S&P 500 Equal Weight Health Care ETF","latestPrice":36.3,"timestamp":1788984000000,"preClose":36.49,"halted":0,"volume":85623,"hourTrading":{"tag":"盘后","latestPrice":36.3,"preClose":36.3,"latestTime":"19:30 EDT","volume":13,"amount":471.83,"timestamp":1788996609938,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.005206906001644418,"floatShares":23090000,"shares":23090000,"eps":0,"marketStatus":"Not Yet Opened","change":-0.19,"latestTime":"09-09 16:00:00 EDT","open":36.41,"high":36.5,"low":36.202,"amount":3113588.093406,"amplitude":0.008167,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789027200000},"marketStatusCode":0,"adr":0,"exchange":"ARCA","adjPreClose":36.49,"sharesOutstanding":23410000,"nav":36.50476,"aum":844355098.8,"dividendRate":0.006433,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":36,"preClose":36.49,"latestTime":"08:32 EDT","volume":998,"amount":36412.121816,"timestamp":1788957172748,"change":-0.49,"changeRate":-0.013428,"amplitude":0.013428},"postHourTrading":{"tag":"盘后","latestPrice":36.3,"preClose":36.3,"latestTime":"19:30 EDT","volume":13,"amount":471.83,"timestamp":1788996609938,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.286844,"impliedVol":0.3468,"impliedVolPercentile":0.9801},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RSPH\",,,,,undefined,":{"symbol":"RSPH","floatShares":23090000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.286844,"shares":23090000,"dividePrice":0.2335,"high":36.5,"amplitude":0.008167,"preClose":36.49,"low":36.202,"week52Low":28.26,"pbRate":"--","week52High":38.19,"institutionHeld":0,"latestPrice":36.3,"eps":0,"divideRate":0.006433,"volume":85623,"delay":0,"ttmEps":0,"open":36.41,"prevYearClose":31.85,"prevWeekClose":37.45,"prevMonthClose":37.4,"prevQuarterClose":33.19,"fiveDayClose":37.47,"twentyDayClose":36.03,"sixtyDayClose":32.16},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RSPH\",params:#limit:5,,,undefined,":[{"date":"2026-06-22","symbol":"RSPH","amount":0.06267,"announcedDate":"2026-06-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"Invesco S&P 500 Equal Weight Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-26","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-26"},{"date":"2026-03-23","symbol":"RSPH","amount":0.05609,"announcedDate":"2026-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-23","defaultRemindTime":1774272600000,"name":"Invesco S&P 500 Equal Weight Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-27","payableDate":"2026-03-23","currency":"USD","dateTimestamp":1774238400000,"payDate":"2026-03-27"},{"date":"2025-12-22","symbol":"RSPH","amount":0.05305,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"Invesco S&P 500 Equal Weight Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2025-09-22","symbol":"RSPH","amount":0.05991,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"Invesco S&P 500 Equal Weight Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-26","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-26"},{"date":"2025-06-23","symbol":"RSPH","amount":0.05546,"announcedDate":"2025-06-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"Invesco S&P 500 Equal Weight Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-27","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-27"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RSPH\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-16","recordDate":"2016-09-20","paymentDate":"2016-09-30","value":0.198297,"currency":"USD"},{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-30","value":0.174967,"currency":"USD"},{"executeDate":"2023-06-20","recordDate":"2023-06-21","paymentDate":"2023-06-23","value":0.51083,"currency":"USD"},{"executeDate":"2023-09-18","recordDate":"2023-09-19","paymentDate":"2023-09-22","value":0.04794,"currency":"USD"},{"executeDate":"2023-12-18","recordDate":"2023-12-19","paymentDate":"2023-12-22","value":0.04988,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RSPH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RSPH\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1199145560","title":"Tellgen's Subsidiary Device Registration Application Accepted by Regulator","url":"https://stock-news.laohu8.com/highlight/detail?id=1199145560","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199145560?lang=en_us&edition=fundamental","pubTime":"2026-09-10 11:54","pubTimestamp":1789012483,"startTime":"0","endTime":"0","summary":"Tellgen Corporation (SZSE: 300642) has announced that its controlling subsidiary, Shanghai Maishi Biotechnology Co., Ltd., recently had its medical device registration application accepted for review...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159883","BK1100","BK0046","BK1583","MDEV","09996","BK0042","BK0239","MEDX","AGNG","300642","IEIH","PTH","LNGR","GDOC","HART","BK1574","RSPH","LGHT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156894230","title":"LIFETECH SCI's LantvalTM Aortic Valve Replacement System Clears NMPA Fast-Track Review for Innovative Devices","url":"https://stock-news.laohu8.com/highlight/detail?id=1156894230","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1156894230?lang=en_us&edition=fundamental","pubTime":"2026-09-10 08:08","pubTimestamp":1788998900,"startTime":"0","endTime":"0","summary":"LIFETECH SCI (01302) has announced that it received an official written notice from the National Medical Products Administration (NMPA) on September 9, 2026, confirming that the LantvalTM aortic...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01302","BK1600","BK1583","LGHT","BK1100","159883","GDOC","MDEV","PTH","HART","LNGR","IEIH","MEDX","RSPH","AGNG","BK1574","09996"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666530163","title":"Bank of America Reveals 5.22% Indirect Stake in Qiagen","url":"https://stock-news.laohu8.com/highlight/detail?id=2666530163","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666530163?lang=en_us&edition=fundamental","pubTime":"2026-09-10 04:37","pubTimestamp":1788986261,"startTime":"0","endTime":"0","summary":"Qiagen ( ($QGEN) ) has issued an update. QIAGEN N.V., a Netherlands-based life sciences and biotechnology group focused on molecular diagnostics an...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bank-of-america-reveals-5-22-indirect-stake-in-qiagen?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bank-of-america-reveals-5-22-indirect-stake-in-qiagen?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FNCL","LU0314106906.USD","LU0321505868.SGD","BK4581","BMED","IBB","IE00B1BXHZ80.USD","LU0256863902.USD","LU1894683264.USD","LU0070302665.USD","XT","LU2129689431.USD","LU0130517989.USD","LU1280957306.USD","LU1496350502.SGD","SYNB","UYG","AGNG","IE00BKVL7J92.USD","LNGR","TFNS","LU2133065610.SGD","LU1718418525.SGD","PGF","IEIH","DARP","LU1366192091.USD","BBP","BAC","JDOC","XLF","KBWB","RSPH","FTXO","LU1804176565.USD","FHLC","IYF","LU0648000940.SGD","BK4534","FWD","LU0648001328.SGD","LU0208291251.USD","VFH","IE00B19Z3581.USD","HTEC","IYG","LU0256863811.USD","GNMX","HELX","BK4582"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666458412","title":"Revvity to acquire Human Cell Design","url":"https://stock-news.laohu8.com/highlight/detail?id=2666458412","media":"TIPRANKS","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666458412?lang=en_us&edition=fundamental","pubTime":"2026-09-09 18:05","pubTimestamp":1788948328,"startTime":"0","endTime":"0","summary":"Revvity (RVTY) announced it has entered into a definitive agreement to acquire Human Cell Design, or HCD, a France-based biotechnology company spec...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/revvity-to-acquire-human-cell-design-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/revvity-to-acquire-human-cell-design-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AGNG","SYNB","IE00BLDYK493.USD","XT","BK4588","LNGR","FWD","BK4121","JDOC","RSPH","BK4585","IBB","DARP","IE00BN0W2V16.EUR","BBP","IEIH","IE00B64QTZ34.USD","FHLC","RVTY","IE00BN0W2T93.GBP","IE00BN0W2W23.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666301843","title":"Actinogen Medical Expands ASX-Quoted Share Base","url":"https://stock-news.laohu8.com/highlight/detail?id=2666301843","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666301843?lang=en_us&edition=fundamental","pubTime":"2026-09-09 10:52","pubTimestamp":1788922334,"startTime":"0","endTime":"0","summary":"An announcement from Actinogen Medical ( ($AU:ACW) ) is now available. Actinogen Medical Limited, a biotechnology company listed on the ASX under t...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/actinogen-medical-expands-asx-quoted-share-base?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/actinogen-medical-expands-asx-quoted-share-base?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IEIH","RSPH","FHLC","BK4585","FWD","IBB","LNGR","SYNB","JDOC","XT","BBP","DARP","BK4588","AGNG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666377632","title":"Structure weakness ‘disconnected’ from underlying data, says Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2666377632","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666377632?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:00","pubTimestamp":1788897615,"startTime":"0","endTime":"0","summary":"After Structure Therapeutics (GPCR) reported clinical trial results from its two lead product candidates, ACCG-2671 and aleniglipron, Jefferies see...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/structure-weakness-disconnected-from-underlying-data-says-jefferies-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/structure-weakness-disconnected-from-underlying-data-says-jefferies-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CANC","BME","NVIB","IBBJ","FTXH","GPCR","CURE","RSPH","SYNB","PSCH","CNCR","PBPH","MEDI","PTH","SURI","APXH","PSIL","BBH","FBT","PINK","JDOC","LFSC","IDNA","XPH","MNTL","GNMX","TBXU","GDOC","BBP","FXH","MDTX","HYLG","HRTS","BIB","SBIO","IEIH","WDNA","AZNH","GSKH","IBBQ","PJP","IBRN","MEDX","JHMH","MRNY","GNOM","IBB","LLYX","FHLC","PBE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665637847","title":"Structure Therapeutics reports ACCG-2671, aleniglipron trial results","url":"https://stock-news.laohu8.com/highlight/detail?id=2665637847","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665637847?lang=en_us&edition=fundamental","pubTime":"2026-09-08 20:36","pubTimestamp":1788871007,"startTime":"0","endTime":"0","summary":"Structure Therapeutics (GPCR) reported clinical trial results from its two lead product candidates: ACCG-2671, an oral, non-peptide, small molecule...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/structure-therapeutics-reports-accg-2671-aleniglipron-trial-results-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/structure-therapeutics-reports-accg-2671-aleniglipron-trial-results-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HRTS","GNMX","IBBJ","MDTX","CURE","JDOC","GNOM","MEDI","WDNA","PSIL","IBRN","PJP","APXH","LFSC","TBXU","HYLG","SYNB","IDNA","IBBQ","MRNY","NVIB","PTH","FHLC","GDOC","FXH","XPH","PSCH","JHMH","BIB","BBH","IBB","LENZ","GPCR","BBP","PBPH","MNTL","CANC","FBT","LLYX","RSPH","SBIO","GSKH","BME","PINK","AZNH","SURI","FTXH","CNCR","MEDX","PBE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665340152","title":"CSL Seeks ASX Quotation for New Shares from Employee Incentive Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2665340152","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665340152?lang=en_us&edition=fundamental","pubTime":"2026-09-08 14:53","pubTimestamp":1788850386,"startTime":"0","endTime":"0","summary":"CSL ( ($AU:CSL) ) has provided an announcement. CSL Limited is a global biotechnology company that develops and supplies vaccines, plasma-derived t...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/csl-seeks-asx-quotation-for-new-shares-from-employee-incentive-plan?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/csl-seeks-asx-quotation-for-new-shares-from-employee-incentive-plan?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBP","BK4585","LNGR","AGNG","RSPH","FHLC","BK4588","IBB","JDOC","PBPH","XT","SYNB","FWD","IEIH","DARP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665344433","title":"Ceryvyn Therapeutics Plans Issue of 3 Million Long-Dated Options","url":"https://stock-news.laohu8.com/highlight/detail?id=2665344433","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665344433?lang=en_us&edition=fundamental","pubTime":"2026-09-08 12:37","pubTimestamp":1788842272,"startTime":"0","endTime":"0","summary":"Opthea ( ($AU:CYV) ) just unveiled an update. Ceryvyn Therapeutics Limited, an ASX-listed biotechnology company trading under the code CYV, develop...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ceryvyn-therapeutics-plans-issue-of-3-million-long-dated-options?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ceryvyn-therapeutics-plans-issue-of-3-million-long-dated-options?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BBP","BK4539","FHLC","LNGR","JDOC","FWD","AGNG","BK4139","SYNB","DARP","LENZ","XT","RSPH","IEIH","BK4585","IBB","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106413707","title":"China Securities Reports Medical Device Sector Sustains Earnings Improvement While Medical Services Revenue Grows Steadily","url":"https://stock-news.laohu8.com/highlight/detail?id=1106413707","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1106413707?lang=en_us&edition=fundamental","pubTime":"2026-09-08 11:34","pubTimestamp":1788838468,"startTime":"0","endTime":"0","summary":"China Securities has released a research note indicating that the medical device sector maintained its revenue growth trajectory in Q2, with quarterly profit growth turning positive for the first...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1100","159883","BK1583","IEIH","PTH","HART","601066","MEDX","GDOC","LGHT","BK1574","LNGR","MDEV","BK0276","RSPH","AGNG","09996"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185411766","title":"Novo Nordisk's GLP-1 Drug Shows Promise in Reducing Childhood Obesity in Younger Kids","url":"https://stock-news.laohu8.com/highlight/detail?id=1185411766","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185411766?lang=en_us&edition=fundamental","pubTime":"2026-09-07 20:20","pubTimestamp":1788783624,"startTime":"0","endTime":"0","summary":"Novo Nordisk (NVO.US) announced on Monday that in a late-stage clinical trial, its blockbuster weight-loss drug Wegovy's active ingredient, semaglutide, helped 40.4% of children aged 6 to under 12...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FHLC","TRUH","THNR","IYH","NBDS","CURE","RSPH","NVOH","BGIA","NVOC","PINK","XLVI","FXH","MEDI","PJP","NVOX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155170383","title":"Medical Device Inspection Campaign Launched by Ningyang County Market Regulators","url":"https://stock-news.laohu8.com/highlight/detail?id=1155170383","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155170383?lang=en_us&edition=fundamental","pubTime":"2026-09-07 12:41","pubTimestamp":1788756073,"startTime":"0","endTime":"0","summary":"On September 7, enforcement officers from the Market Supervision Administration of Ningyang County, Shandong Province, visited retail pharmacies within their jurisdiction to conduct a targeted...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGNG","LGHT","09996","LNGR","GDOC","BK1583","IEIH","159883","MEDX","BK1574","PTH","RSPH","HART","BK1100","MDEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191894169","title":"MedTech Firm Joins Hong Kong Market: Evaluating MEDCAPTAIN's (02041) True Investment Potential","url":"https://stock-news.laohu8.com/highlight/detail?id=1191894169","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191894169?lang=en_us&edition=fundamental","pubTime":"2026-09-07 12:18","pubTimestamp":1788754720,"startTime":"0","endTime":"0","summary":"As a wave of interim earnings reports floods in from medical device companies, the sector's recovery trajectory has become increasingly clear, with a definitive upward inflection point now visible in...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","AGNG","02041","MEDX","09996","159883","BK4585","LNGR","IEIH","BK1100","BK4588","PTH","BK1583","VXUS","MDEV","GDOC","HART","RSPH","KCAI","LGHT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665396581","title":"Qurient Plans Investor Roadshow at 2026 KIS BioTech Day in Singapore and Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2665396581","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665396581?lang=en_us&edition=fundamental","pubTime":"2026-09-07 11:12","pubTimestamp":1788750740,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Qurient Co., Ltd. ( ($KR:115180) ). Qurient Co., Ltd., a Korea-based biotechnology company, is seeking to raise...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/qurient-plans-investor-roadshow-at-2026-kis-biotech-day-in-singapore-and-hong-kong?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/qurient-plans-investor-roadshow-at-2026-kis-biotech-day-in-singapore-and-hong-kong?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SYNB","STmain","BBP","BK4588","XT","IEIH","DARP","FHLC","BK4585","LNGR","JDOC","FWD","IBB","AGNG","RSPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121796426","title":"Brain-Computer Interface Startups Must Walk the Line Between Vast Potential and Near-Term Medical Reality, Says Formatia Founder","url":"https://stock-news.laohu8.com/highlight/detail?id=1121796426","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121796426?lang=en_us&edition=fundamental","pubTime":"2026-09-05 14:10","pubTimestamp":1788588618,"startTime":"0","endTime":"0","summary":"At the 2026 Yabuli Forum Summer Annual Meeting, held September 4-6 in Chengdu, Sichuan, under the theme \"Enterprise Innovation and Cycle Crossing,\" Formatia Founder and CEO Peng Lei offered a...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGNG","MNTL","PTH","09996","BK1583","HART","MEDX","RSPH","IBRN","GDOC","159883","BK1100","IEIH","BK1574","LGHT","LNGR","MDEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665354019","title":"Guardant announces FDA approval of Guardant360 CDx as companion diagnostic","url":"https://stock-news.laohu8.com/highlight/detail?id=2665354019","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665354019?lang=en_us&edition=fundamental","pubTime":"2026-09-05 06:15","pubTimestamp":1788560112,"startTime":"0","endTime":"0","summary":"Guardant Health (GH) announced that the U.S. Food and Drug Administration has approved Guardant360 CDx as a companion diagnostic to identify patien...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/guardant-announces-fda-approval-of-guardant360-cdx-as-companion-diagnostic-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/guardant-announces-fda-approval-of-guardant360-cdx-as-companion-diagnostic-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4551","HELX","PSCH","GDOC","LU0889565916.HKD","IYH","MRNX","LU0109394709.USD","GH","LFSC","LABU","FFOX","IBB","TBXU","PINK","GNOM","SYNB","IEIH","RSPH","PTH","BK4535","BK4585","EKG","BBP","BMED","BK4588","MEDI","MRNY","LU0320765992.SGD","XLVX","IDNA","NVIB","TECB","GNMX","FRTY","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665355353","title":"AcroMeta Moves Into Cell Therapy Logistics With Southeast Asia ATCLS Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2665355353","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665355353?lang=en_us&edition=fundamental","pubTime":"2026-09-05 00:46","pubTimestamp":1788540418,"startTime":"0","endTime":"0","summary":"AcroMeta Group Limited ( ($SG:43F) ) just unveiled an announcement. AcroMeta Group Limited has signed a non-binding term sheet with biotechnology f...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/acrometa-moves-into-cell-therapy-logistics-with-southeast-asia-atcls-deal?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/acrometa-moves-into-cell-therapy-logistics-with-southeast-asia-atcls-deal?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBP","BK4588","BK4209","IBB","XT","FHLC","IEIH","RSPH","DARP","AGNG","JDOC","LNGR","SG","BK4585","FWD","SYNB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664928878","title":"SD Biotechnologies Faces KOSDAQ Delisting Decision After Improvement Period","url":"https://stock-news.laohu8.com/highlight/detail?id=2664928878","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664928878?lang=en_us&edition=fundamental","pubTime":"2026-09-03 17:15","pubTimestamp":1788426920,"startTime":"0","endTime":"0","summary":"SD Biotechnologies Co., Ltd. ( ($KR:217480) ) has issued an update. SD Biotechnologies Co., Ltd., a KOSDAQ-listed biotechnology company, is under r...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/sd-biotechnologies-faces-kosdaq-delisting-decision-after-improvement-period?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/sd-biotechnologies-faces-kosdaq-delisting-decision-after-improvement-period?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LNGR","BK4585","BK4588","BBP","AGNG","SYNB","FWD","JDOC","XT","IBB","FHLC","RSPH","IEIH","DARP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121486923","title":"Yinchuan Market Regulators Roll Out Comprehensive Measures to Implement Revised Medical Device Production Quality Standards","url":"https://stock-news.laohu8.com/highlight/detail?id=1121486923","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121486923?lang=en_us&edition=fundamental","pubTime":"2026-09-03 16:00","pubTimestamp":1788422444,"startTime":"0","endTime":"0","summary":"The Yinchuan Municipal Market Supervision Administration in Ningxia is advancing a multi-pronged strategy to ensure the smooth implementation of the newly revised Medical Device Production Quality...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDX","RSPH","BK1583","MDEV","159883","BK1574","09996","AGNG","LNGR","IEIH","GDOC","LGHT","BK1100","PTH","HART"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664214842","title":"Alterity Therapeutics to Spotlight MSA Program at Cantor Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2664214842","media":"TIPRANKS","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664214842?lang=en_us&edition=fundamental","pubTime":"2026-09-03 07:47","pubTimestamp":1788392845,"startTime":"0","endTime":"0","summary":"Alterity Therapeutics ( ($AU:ATH) ) has provided an update. Alterity Therapeutics, a clinical-stage biotechnology company developing disease-modify...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/alterity-therapeutics-to-spotlight-msa-program-at-cantor-global-healthcare-conference?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/alterity-therapeutics-to-spotlight-msa-program-at-cantor-global-healthcare-conference?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BBP","LU0128526141.USD","XLV","RSPH","LNGR","SYNB","LU0029874061.USD","FWD","XBI","BBC","BK4137","BK4139","DARP","JDOC","LENZ","IBB","BK4581","AGNG","FHLC","BK4585","BK4539","BK4007","BK4588","IEIH","HCSG","XT"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":195,"code":"91000000","status":"200"}]}}